Skye Bioscience SKYE
NASDAQ SKYE
$0.28 0.00 (-0.32%)
At close: Aug 21, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Receivables - Net (2012 - 2014)

Skye Bioscience (SKYE) posted quarterly Receivables - Net of $35425.0 for Q2 2014, up 10.43% year-over-year from $32078.0 in Q2 2013, and up 39.81% quarter-over-quarter from $25338.0 in Q4 2013.

Skye Bioscience (SKYE) Receivables - Net (2012 - 2014) Analysis & Trends

Skye Bioscience (SKYE) has reported Receivables - Net for 3 consecutive years, with $35425.0 the latest figure, recorded in Q2 2014.

  • In Q2 2014, Receivables - Net rose 10.43% year-over-year to $35425.0; the TTM figure through Apr 2014 stood at $35425.0 (up 10.43% YoY), while the FY2013 annual figure was $25338.0, up 266.9% from the prior year.
  • Receivables - Net improved to $35425.0 in Q2 2014 per SKYE's latest filing, from $25338.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $35425.0 in Q2 2014 and bottomed at $6906.0 in Q4 2012.
  • Historically, Receivables - Net has averaged $25682.6 across 3 years, with a median of $28666.0 in 2013.
  • Annual changes were most pronounced in 2013 — Receivables - Net surged 266.9% — and 2014, when it grew 10.43%.
  • Skye Bioscience's Receivables - Net stood at $6906.0 in 2012, then soared by 266.9% to $25338.0 in 2013, then soared by 39.81% to $35425.0 in 2014.
  • Business Quant data shows SKYE's Receivables - Net at $35425.0 in Q2 2014, $25338.0 in Q4 2013, and $28666.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Skye Bioscience 10.86 Mn 10.86 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2014 35,425.00
Apr 30, 2014 35,425.00
Oct 31, 2013 25,338.00
Oct 31, 2013 25,338.00
Jul 31, 2013 28,666.00
Jul 31, 2013 28,666.00
Apr 30, 2013 32,078.00
Apr 30, 2013 32,078.00
Oct 31, 2012 6,906.00
Oct 31, 2012 6,906.00